ReportGemReportGem 中文

PUBLIC COMPANY RESEARCH HUB

AZN.L (AZN.L) Foreign Research Coverage

A focused collection of foreign research coverage for AZN.L, organized by institution and publication date for faster discovery.

Evidence documents4
Filings0
Meetings0
Research4
Displayed research share100%
Latest evidence2026-08-20

Foreign research

Keymed (2162.HK) 1H26 Result: Stapokibart FY26 Guidance Raised; Catalyst Rich in 2H26 and 1H272026-08-20 · CitiAstraZeneca: Weekly retail Rx tracker2026-07-27 · Deutsche BankAstraZeneca: Post-Q2: updating after the pipeline deluge, still awaiting main events2026-07-27 · Deutsche BankAstraZeneca: Q2 first take2026-07-27 · Deutsche Bank

Questions this evidence can help answer

  • What changed in the latest research coverage of AZN.L?
  • Which operating and valuation themes recur across institutions?
  • Which claims should be checked against company primary-source evidence?
Research this company with AI